1. Combined Submyeloablative and Myeloablative Dose Intense Melphalan Results in Satisfactory Responses with Acceptable Toxicity in Patients with Multiple Myeloma 
Nicolas Novitzky, Jaqueline Thomson, Valda Thomas, Cecile du Toit, Zainab Mohamed, Andrew McDonald 
Biology of Blood and Marrow Transplantation 
Volume 16, Issue 10, Pages (October 2010)
DOI: /j.bbmt
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Graphical representation of the laboratory parameters and of Karnofsky scores at the different stages of the described therapeutic strategy. All the values are significantly different from the presentation parameters. (Dexa: dexamethasone; SCT 1 and 2: stem cell transplant 1 and 2).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
OS of the study population. (A) Shows the overall outcome. (B) Shows the outcome according to type of response to the therapeutic strategy. Patients who failed to achieve at least VGPR had significantly worse outcome.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions